Adial Pharmaceuticals, Inc. (ADIL) SEC Filing 10-Q Quarterly report for the period ending Saturday, June 30, 2018

Adial Pharmaceuticals, Inc.

CIK: 1513525 Ticker: ADIL
Document and Entity Information - shares
6 Months Ended
Jun. 30, 2018
Sep. 06, 2018
Document And Entity Information  
Entity Central Index Key0001513525 
Amendment Flagfalse 
Trading SymbolADIL 
Current Fiscal Year End Date--12-31 
Document Type10-Q 
Document Period End DateJun. 30, 2018 
Document Fiscal Period FocusQ2 
Document Fiscal Year Focus2018 
Entity Filer CategoryNon-accelerated Filer 
Entity Common Stock, Shares Outstanding 6,556,249

View differences made from one quarter to another to evaluate Adial Pharmaceuticals, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Adial Pharmaceuticals, Inc..


Assess how Adial Pharmaceuticals, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Adial Pharmaceuticals, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 10-Q Quarterly Report

Material Contracts, Statements, Certifications & more

Adial Pharmaceuticals, Inc. provided additional information to their SEC Filing as exhibits

Ticker: ADIL
CIK: 1513525
Form Type: 10-Q Quarterly Report
Accession Number: 0001213900-18-012298
Submitted to the SEC: Fri Sep 07 2018 8:54:33 PM EST
Accepted by the SEC: Mon Sep 10 2018
Period: Saturday, June 30, 2018
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: